{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:52:36Z","timestamp":1761540756228},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":6219,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1989,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Twelve infusions of plasma concentrates of von Willebrand factor (vWF) were given to four patients with severe (type III) von Willebrand disease (vWD). Their prolonged bleeding times were either completely or partially corrected after five infusions and had not changed after the remaining seven. In contrast, the low platelet coverage of the subendothelial surface of rabbit aorta perfused with normal washed platelets and red cells resuspended in preinfusion patient plasma was completely or partially corrected in ten instances by replacing preinfusion plasma with postinfusion plasma and remained unchanged in two. Postinfusion improvement in surface coverage was greater than that in bleeding time, suggesting that vWF from normal platelets is needed to support optimal platelet\u2010vessel wall interactions in vWD. This possibility was further explored through other perfusion experiments. The subendothelial surface covered by platelets from an untreated patient with type III vWD (containing no measurable vWF) or from a type IIA vWD patient (containing dysfunctional vWF) resuspended in normal plasma was much smaller than that covered by normal platelets resuspended in normal plasma. These results establish that platelet vWF is important in supporting platelet\u2010vessel wall interactions in vWD and also provide experimental support in favour of the therapeutic transfusion of normal platelets in addition to vWF concentrates to correct the bleeding time in vWD patients.<\/jats:p>","DOI":"10.1002\/ajh.2830310303","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T11:44:46Z","timestamp":1172058286000},"page":"153-158","source":"Crossref","is-referenced-by-count":12,"title":["Role for platelet von willebrand factor in supporting platelet\u2010vessel wall interactions in von willebrand disease"],"prefix":"10.1002","volume":"31","author":[{"given":"R.","family":"Castillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ordinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830250106"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: Evidence for a subgroup with an abnormal von Willebrand factor","volume":"66","author":"Mannucci PM","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.1.58.58"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112560"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood.V51.4.751.751","article-title":"Platelet factor VIII related antigen: studies in vivo after transfusion in patients with von Willebrand disease","volume":"51","author":"Sultan Y","year":"1978","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-2862(73)90069-1"},{"key":"e_1_2_1_8_2","first-page":"23","volume-title":"Platelets in Biology and Pathology","author":"Baumgartner HR","year":"1976"},{"key":"e_1_2_1_9_2","first-page":"132","article-title":"Factor VIII\u2010related properties in platelets from patients with von Willebrand's disease","volume":"91","author":"Ruggeri ZM","year":"1978","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP: Implications for pathophysiology and therapy of von Willebrand's disease subtypes","volume":"59","author":"Ruggeri ZM","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V31.5.604.604"},{"key":"e_1_2_1_12_2","first-page":"1","article-title":"Interaction of microtubules and microfilaments in platelet contractile physiology","volume":"9","author":"White JG","year":"1979","journal-title":"Methods Achiev Exp Pathol"},{"key":"e_1_2_1_13_2","first-page":"8","article-title":"Development of a computer program to analyze the parameters of platelet\u2010vessel wall interaction","volume":"16","author":"Escolar G","year":"1986","journal-title":"Haemostasis"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1661159"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V70.4.1214.1214","article-title":"Platelet von Willebrand factor: Evidence for its involvement in platelet adhesion to collagen","volume":"70","author":"Fressinaud E","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1649196","article-title":"Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with \u03b1\u2010chymotrypsin digested subendothelium","volume":"37","author":"Baumgartner HR","year":"1977","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111591"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830310303","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830310303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T02:19:38Z","timestamp":1697941178000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830310303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["10.1002\/ajh.2830310303"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830310303","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}